JUST RELEASED

XpertPatient Launches Survivor-Led Cancer Education Platform for Newly Diagnosed Patients and Caregivers

 

XpertGuided™ connects newly diagnosed and progressed cancer patients with survivor-led guidance, enabling oncology brands to engage high-intent audiences during the critical pre-treatment decision window

 

NEW YORK – April 14, 2026 – PRLog — XpertPatient.com today announced the launch of XpertGuided™, a survivor-led cancer education platform. The experience is designed to support newly diagnosed and progressed cancer patients and caregivers during the most critical phases of their journey: the pre-treatment decision window (Day 1 through Week 5).

When a cancer diagnosis turns your world upside down, who do you turn to?  The moment is unlike any other. Patients and their families are suddenly flooded with information they don’t yet have the language to process — and forced to make life-altering decisions they never expected to face. Most turn to the internet. What they find rarely reflects what they need.

XpertPatient.com is changing that.

XpertGuided™ addresses this gap by connecting patients with survivors who have experienced similar diagnoses and treatment decisions, providing real-world guidance, emotional support, and practical insight when it matters most.

The platform delivers stage-specific, easy-to-understand education shaped by lived experience and enhanced by AI to simplify complex clinical information and personalize the experience based on patient needs.

8x Award-Winning Cancer Education Experience

“XpertGuided is redefining how patients experience cancer education at the moment they need it most,” said Risa L. Arin, Founder and CEO of XpertPatient. “By combining survivor insights and our award-winning design, we are helping patients & caregivers better understand their options—while enabling brand engagement during critical decision-making moments.”

For pharmaceutical companies, XpertPatient provides a new model for oncology engagement—enabling brands to reach high-intent audiences at diagnosis and progression, when treatment decisions are actively being evaluated.

Redefining Oncology Media – Platform Capabilities:

• Precision reach at diagnosis and disease progression
• Survivor-led, stage-specific education experiences
• Long-duration engagement in a premium, brand-safe environment
• 100% share of voice sponsorships aligned to cancer type and treatment stage

This approach enables engagement during the highest-value pre-treatment decision window, when patients are most receptive to education and guidance.

The XpertGuided experience is currently live within the XpertPatient Breast Cancer Center with additional Cancer Centers launching later in 2026. Reach out today to learn about available Flagship Sponsorship opportunities.

XpertPatient, The Cancer Specialty Publisher

XpertPatient.com is a premium oncology platform connecting newly diagnosed patients and caregivers with survivor-led guidance.  For pharmaceutical brands we deliver high-intent audience reach and engagement during the highest-value pre-treatment decision window.